2/23
10:25 am
alny
Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
2/23
10:00 am
alny
Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference
Low
Report
Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference
2/20
05:21 pm
alny
Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge [Yahoo! Finance]
Low
Report
Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge [Yahoo! Finance]
2/19
07:25 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at Freedom Capital from a "hold" rating to a "strong-buy" rating.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at Freedom Capital from a "hold" rating to a "strong-buy" rating.
2/18
12:22 pm
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $510.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $510.00 price target on the stock.
2/18
04:32 am
alny
Assessing Alnylam Pharmaceuticals (ALNY) Valuation As Mixed Share Price Returns Meet Bullish Fair Value Models [Yahoo! Finance]
Low
Report
Assessing Alnylam Pharmaceuticals (ALNY) Valuation As Mixed Share Price Returns Meet Bullish Fair Value Models [Yahoo! Finance]
2/17
09:41 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target raised by analysts at Canaccord Genuity Group Inc. from $415.00 to $429.00. They now have a "buy" rating on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target raised by analysts at Canaccord Genuity Group Inc. from $415.00 to $429.00. They now have a "buy" rating on the stock.
2/14
01:50 am
alny
Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now? [Yahoo! Finance]
Medium
Report
Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now? [Yahoo! Finance]
2/13
10:30 pm
alny
Alnylam Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medium
Report
Alnylam Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/13
03:12 pm
alny
Alnylam Hit Hard As Investors Forced To Revise Future Profit Expectations [Seeking Alpha]
Low
Report
Alnylam Hit Hard As Investors Forced To Revise Future Profit Expectations [Seeking Alpha]
2/13
08:02 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Chardan Capital from $475.00 to $425.00. They now have a "buy" rating on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Chardan Capital from $475.00 to $425.00. They now have a "buy" rating on the stock.
2/12
04:17 pm
alny
Alnylam Pharmaceuticals, Inc. (ALNY) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Alnylam Pharmaceuticals, Inc. (ALNY) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/12
02:08 pm
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "buy" rating reaffirmed by analysts at Bank of America Corporation.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "buy" rating reaffirmed by analysts at Bank of America Corporation.
2/12
02:04 pm
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Needham & Company LLC from $529.00 to $510.00. They now have a "buy" rating on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Needham & Company LLC from $529.00 to $510.00. They now have a "buy" rating on the stock.
2/12
08:27 am
alny
Alnylam: Q4 Earnings Snapshot [Yahoo! Finance]
Low
Report
Alnylam: Q4 Earnings Snapshot [Yahoo! Finance]
2/12
08:00 am
alny
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Period Progress
Medium
Report
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Period Progress
2/9
06:28 am
alny
Does Alnylam Pharmaceuticals (NASDAQ:ALNY) Have A Healthy Balance Sheet? [Yahoo! Finance]
Low
Report
Does Alnylam Pharmaceuticals (NASDAQ:ALNY) Have A Healthy Balance Sheet? [Yahoo! Finance]
2/8
09:20 pm
alny
???????????????????? : ?????????????????????????????????????????2033??????????24%?1512??????????? [CNET News]
Low
Report
???????????????????? : ?????????????????????????????????????????2033??????????24%?1512??????????? [CNET News]
2/1
12:32 am
alny
Alnylam Pharmaceuticals (ALNY) Valuation Check After Recent Share Price Weakness [Yahoo! Finance]
Low
Report
Alnylam Pharmaceuticals (ALNY) Valuation Check After Recent Share Price Weakness [Yahoo! Finance]
1/31
07:03 pm
alny
Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth [Yahoo! Finance]
Low
Report
Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth [Yahoo! Finance]
1/30
12:26 pm
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Morgan Stanley from $495.00 to $408.00. They now have an "equal weight" rating on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Morgan Stanley from $495.00 to $408.00. They now have an "equal weight" rating on the stock.
1/30
08:03 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at HC Wainwright from $570.00 to $510.00. They now have a "buy" rating on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at HC Wainwright from $570.00 to $510.00. They now have a "buy" rating on the stock.
1/30
08:03 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Bank of America Corporation from $529.00 to $462.00. They now have a "buy" rating on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Bank of America Corporation from $529.00 to $462.00. They now have a "buy" rating on the stock.
1/29
08:00 am
alny
Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results
1/28
08:03 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $527.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $527.00 price target on the stock.